Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 26, 2024
Cystic fibrosis foundation position paper: Redefining the cystic fibrosis care team
Rebekah F Brown, Charlotte T Close, Molly G Mailes, et al.
Annals of the American Thoracic Society
|
April 12, 2021
Development and Validation of a Clinical Diagnostic Scoring System for the Diagnosis of Idiopathic Pulmonary Fibrosis
Jean Pastre, Scott D Barnett, Inga Ksovreli, et al.
Clinical Microbiology Reviews
|
August 19, 2024
Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis
Lisa Saiman, Valerie Waters, John J LiPuma, et al.
Respiratory Research
|
May 21, 2022
Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study
Ganesh Raghu, Mark J Hamblin, A Whitney Brown, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
October 13, 2022
Remote ex vivo lung perfusion at a centralized evaluation facility
Jorge M Mallea, Matthew G Hartwig, Cesar A Keller, et al.
Plos One
|
November 23, 2020
Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure
Christopher S King, Dhwani Sahjwani, A Whitney Brown, et al.
JAMA
|
May 26, 2018
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial
Ganesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
The Lancet. Respiratory Medicine
|
May 25, 2019
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
Ganesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
December 30, 2025
Financial and healthcare tradeoffs associated with cystic fibrosis care in the United States: A cross-sectional study
Aricca D Van Citters, Karen Carey, Clement L Ren, et al.
Journal of Thoracic Disease
|
May 22, 2025
North American expert consensus on the clinical role of ex vivo lung perfusion (EVLP) with acellular perfusate
Matthew Bacchetta, Christian A Bermudez, Ankit Bharat, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 26, 2024
Cystic fibrosis foundation position paper: Redefining the cystic fibrosis care team
Rebekah F Brown, Charlotte T Close, Molly G Mailes, et al.
Annals of the American Thoracic Society
|
April 12, 2021
Development and Validation of a Clinical Diagnostic Scoring System for the Diagnosis of Idiopathic Pulmonary Fibrosis
Jean Pastre, Scott D Barnett, Inga Ksovreli, et al.
Clinical Microbiology Reviews
|
August 19, 2024
Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis
Lisa Saiman, Valerie Waters, John J LiPuma, et al.
Respiratory Research
|
May 21, 2022
Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study
Ganesh Raghu, Mark J Hamblin, A Whitney Brown, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
October 13, 2022
Remote ex vivo lung perfusion at a centralized evaluation facility
Jorge M Mallea, Matthew G Hartwig, Cesar A Keller, et al.
Plos One
|
November 23, 2020
Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure
Christopher S King, Dhwani Sahjwani, A Whitney Brown, et al.
JAMA
|
May 26, 2018
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial
Ganesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
The Lancet. Respiratory Medicine
|
May 25, 2019
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
Ganesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
December 30, 2025
Financial and healthcare tradeoffs associated with cystic fibrosis care in the United States: A cross-sectional study
Aricca D Van Citters, Karen Carey, Clement L Ren, et al.
Journal of Thoracic Disease
|
May 22, 2025
North American expert consensus on the clinical role of ex vivo lung perfusion (EVLP) with acellular perfusate
Matthew Bacchetta, Christian A Bermudez, Ankit Bharat, et al.
Page
of 8